Hepatitis B treatment eligibility in West Africa: Uncertainties and need for prospective cohort studies.
Antoine JaquetMarcellin NouamanJudicaël TineAristophane TanonCamille AnomaAndré InwoleyAlain AttiaDidier K EkoueviMoussa SeydiFrançois DabisGilles WandelerPublished in: Liver international : official journal of the International Association for the Study of the Liver (2017)
Among vulnerable populations in West Africa, a minority of HBV-infected individuals were eligible for immediate antiviral therapy. Prospective cohort studies are necessary to evaluate anti-HBV treatment eligibility facing the significant proportion of individuals with active chronic HBV infection.